
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin... Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Kyverna's pipeline includes next-generation chimeric antigen receptor T-cell (CAR T) therapies in both autologous and allogeneic formats with properties well suited for use in B cell-driven autoimmune diseases. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.075 | 2.58620689655 | 2.9 | 3.2397 | 2.645 | 471979 | 2.86564356 | CS |
4 | -0.365 | -10.9281437126 | 3.34 | 4.0593 | 2.645 | 493324 | 3.27480482 | CS |
12 | -1.905 | -39.0368852459 | 4.88 | 7.2 | 2.645 | 402755 | 3.92439024 | CS |
26 | -3.805 | -56.1209439528 | 6.78 | 8.78 | 2.645 | 364786 | 4.91601512 | CS |
52 | -26.315 | -89.8429498122 | 29.29 | 30.6 | 2.645 | 434166 | 10.36212741 | CS |
156 | -31.275 | -91.3138686131 | 34.25 | 35.01 | 2.645 | 443115 | 11.28142398 | CS |
260 | -31.275 | -91.3138686131 | 34.25 | 35.01 | 2.645 | 443115 | 11.28142398 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions